Infliximab

170277-31-3

CAS-Nr.: 170277-31-3

Englisch Name:: Infliximab

Synonyma:: Avakine;CT-P 13;Remicade;Infiximab;Unii-B72hh48flu;Infliximab solution;Infliximab 6.1mg/mg;Infliximab USP/EP/BP;Infliximab (10 mg/ml);Infliximab（170277-31-3）

CBNumber:: CB01116807

Summenformel:

Molgewicht:: 0

MOL-Datei:: Mol file

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 111

Infliximab Eigenschaften

storage temp.: Store at -30°C

Aggregatzustand: Solid

Farbe: White to off-white

Sicherheit

Giftige Stoffe Daten	170277-31-3(Hazardous Substances Data)

Infliximab Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Infliximab targets the transcription factor NF-κB with harmine and related compounds for treatment of cancers and inflammatory diseases and combination with other agents

Infliximab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Infliximab Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 111)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Sinoway Industrial co., ltd.	+86-0592-5800732 +86-13806035118	xie@china-sinoway.com	China	1275	58
Hubei xin bonus chemical co. LTD	86-13657291602	linda@hubeijusheng.com	CHINA	22963	58
TargetMol Chemicals Inc.	+1-781-999-5354; +17819995354	marketing@targetmol.com	United States	32435	58
Hubei Ipure Biology Co., Ltd	+8613367258412	ada@ipurechemical.com	China	10237	58
Shanghai Minbiotech Co., Ltd.	+8617315815539	sales@minbiotech.com	CHINA	129	58
Dideu Industries Group Limited	+86-29-89586680 +86-15129568250	1026@dideu.com	China	20284	58
AFINE CHEMICALS LIMITED	+86-0571-85134551	sales@afinechem.com	China	15106	58
Baoji Guokang Healthchem co.,ltd	+8615604608665 15604608665	dominicguo@gk-bio.com	CHINA	9414	58
Hefei Hirisun Pharmatech Co., Ltd	+8615056975894	shawn@hirisunpharm.com	CHINA	9911	58
Nantong HI-FUTURE Biology Co., Ltd.	+undefined18051384581	sales@chemhifuture.com	China	3135	58

170277-31-3()Verwandte Suche:

Benzylisocyanid Dichloro(ethylendiamin)platin Tris(2,2,6,6-tetramethylheptan-3,5-dionato-O,O')dysprosium 2-Methylpropylisocyanid N-Butylisocyanid (Ethylenbis(nitrilomethylidyn)-2,2'-diphenolato)cobalt(II) (Pentan-2,4-dionato-O,O')silber Tris(2,2,6,6-tetramethylheptan-3,5-dionato-O,O')europium Ethylisocyanacetat Kupfer(II)-4-oxopent-2-en-2-olat Phenylselenol 1,1,3,3-Tetramethylbutylisocyanat (p-Toluolsulfonyl)methylisocyanid Tris(pentan-2,4-dionato)eisen(II) Methylisocyanacetat Aluminiumtris(2,4-pentandionato-O,O')

Avakine
Immunoglobulin G, anti-(human tumor necrosis factor) (human-mouse monoclonal ca2 heavy chain), disulfide with human-mouse monoclonal ca2 light chain, dimer
Remicade
Unii-B72hh48flu
CT-P 13
Infliximab USP/EP/BP
Research Grade Infliximab(DHB94403)
TNFR1,Infliximab,anti-inflammatory,Avakine,Tumor Necrosis Factor Receptor,autoimmune,diabetic,TNFR,PTP1B,neuropathy,Inhibitor,TNFR2,monoclonal,TNF Receptor,inhibit,CT-P13
Infliximab (anti-TNF-alpha)
Infiximab
Research Grade Infliximab
Infliximab solution
Infliximab (10 mg/ml)
Infliximab 6.1mg/mg
Infliximab（170277-31-3）
170277-31-3